Introduction
============

Cancer is a major life-threatening disease worldwide. Approximately 14.1 million patients were newly diagnosed with cancer and 8.2 million people died from cancer in 2012 worldwide \[[@b1-crt-2018-143]\]. The global burden of cancer is expected to grow rapidly due to aging population \[[@b2-crt-2018-143]\].

In Korea, cancer accounts for one in four deaths and more than 200,000 new cancer cases were diagnosed in 2014 \[[@b3-crt-2018-143]\]. The number of cancer incidences and deaths are expected to increase with the aging population and westernized lifestyles \[[@b4-crt-2018-143]\]. Additionally, the economic burden of cancer in Korea increased approximately 1.8-fold, from \$11,424 to \$20,858 million, between 2000 and 2010 \[[@b5-crt-2018-143]\].

In this context, cancer statistics are the most important indicator of the national cancer burden and can be used to form cancer prevention and control strategies. This study aims to provide nationwide cancer statistics including the incidence, survival, prevalence, and mortality in 2015.

Materials and Methods
=====================

1. Data sources
---------------

The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980 as a nationwide hospital-based cancer registry. Since 1999, the KCCR has collected cancer incidence data for the entire nation by compiling a nationwide hospital-based KCCR database that contains data from regional cancer registry programs. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually \[[@b6-crt-2018-143]\].

The KCCR constructed the Korea National Cancer Incidence Database (KNCI DB) using hospitals data, 11 population-based registries, and additional medical chart reviews. The KNCI DB contains information regarding the age, sex, address, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, and Surveillance, Epidemiology, and End Results (SEER) stage. The completeness of cancer incidence data for 2015 was estimated to be 98.2% based on the method proposed by Ajiki et al. \[[@b7-crt-2018-143]\]. The mid-year population and cancer mortality data from 1983 to 2015 were obtained from Statistics Korea \[[@b8-crt-2018-143]\]. To ascertain vital status and to calculate survival and prevalence, the KNCI DB was linked to the mortality data and population registration data established by the Ministry of the Interior and Safety.

2. Classification
-----------------

All incident cases were registered according to the International Classification of Diseases for Oncology, third edition \[[@b9-crt-2018-143]\], and converted to the International Classification of Diseases, 10th edition (ICD-10) codes \[[@b10-crt-2018-143]\]. The mortality cases were registered according to ICD-10 codes. All cancer cases were reported based on the 24 cancer types.

3. Statistical analyses
-----------------------

Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The CR was calculated as the total number of incidence/mortality cases divided by the mid-year population for the specified years. The ASR is a weighted average of the age-specific rates, where the weights are the proportions of persons in the corresponding age groups of a standard population \[[@b11-crt-2018-143]\]. In this report, ASRs were calculated using Segi's world standard population \[[@b12-crt-2018-143]\]. The cumulative risk of developing cancer from birth to life expectancy was calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows \[[@b13-crt-2018-143]\]:
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Trends in incidence/mortality rates were summarized as an annual percentage change (APC) by using a Joinpoint regression. APC is the average percentage change of rates and is calculated as follows \[[@b11-crt-2018-143]\]:

A

P

C

=

R

y

\+

1

\-

R

y

R

y

×

100

=

(

e

b

1

\-

1

)

×

100

, where log(*R~y~*)=*b*~0~+*b*~1~y,

log(*R~y~*) is the natural log transformed age standardized rates.

y=year, *b*~0~=intercept, *b*~1~=*slope*

The survival duration for each cancer case was calculated as the interval between the date of the initial diagnosis and the date of death, date of loss to follow-up, or closing date for follow-up. The 5-year relative survival rates (RSRs) were calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year RSRs were evaluated as percentage differences in 5-year RSRs from 1993-1995 and 2011-2015. RSRs were calculated using the Ederer II method \[[@b14-crt-2018-143]\] with some minor corrections, based on an algorithm established by Paul Dickman \[[@b15-crt-2018-143]\].

Prevalent cases were defined as the number of cancer patients alive on January 1, 2016 among all cancer patients diagnosed between 1999 and 2015. Limited-duration prevalences were calculated using SEER\*Stat software. Any p-values less than 0.05 were considered statistically significant. SEER\*Stat 8.2.1 (National Cancer Institute, Bethesda, MD), Joinpoint 4.1.1 (National Cancer Institute), and SAS 9.4 (SAS Institute Inc., Cary, NC) were used in this report.

Selected Findings
=================

1. Incidence
------------

A total of 214,701 cases were newly diagnosed with cancer during 2015 ([Table 1](#t1-crt-2018-143){ref-type="table"}). Of these cases, 113,335 (52.8%) were men and 101,366 (47.2%) were women. Stomach cancer was the most commonly diagnosed cancer in 2015, followed by colorectal, thyroid, lung, and breast cancer. The overall cumulative risk of developing cancer from birth to life expectancy was 35.3%. However, the cumulative risk of developing cancer from birth to life expectancy was higher in men (37.9%) than in women (32.0%) (data not shown).

The total CR and ASR for the overall cancer incidences in 2015 were 421.4 and 258.9 per 100,000, respectively ([Table 2](#t2-crt-2018-143){ref-type="table"}). According to sex, the CRs for all sites combined were 445.2 in men and 397.6 in women. The ASRs were 291.7 and 241.1 in men and women, respectively. Stomach cancer (CR, 76.8) was the most common cancer in men, followed by lung (CR, 66.8), colorectal (CR, 62.5), liver (CR, 46.1), and prostate cancer (CR, 40.1). These five cancers accounted for 65.7% of the newly diagnosed cases in men during the study period. In contrast, thyroid cancer (CR, 77.1) was the most common cancer among women, followed by breast (CR, 75.1), colorectal (CR, 42.7), stomach (CR, 37.9), and lung cancer (CR, 28.4), which five cancers accounted for 65.7% of the cases in women.

2. Mortality
------------

In 2015, the total number of deaths from cancer was 76,855, accounting for 27.9% of all deaths ([Table 3](#t3-crt-2018-143){ref-type="table"}). In terms of sex, 62.0% and 38.0% of cancer deaths occurred in men and women, respectively ([Table 1](#t1-crt-2018-143){ref-type="table"}).

The total CR and ASR for cancer deaths were 150.8 and 82.0 per 100,000, respectively, in 2015 ([Table 4](#t4-crt-2018-143){ref-type="table"}). The total CR and ASR for cancer deaths per 100,000 were higher among men (CR, 187.3; ASR, 119.6) than among women (CR, 114.4; ASR, 54.6).

According to cancer sites, lung cancer (CR, 49.8) was the leading cause of death in men, followed by liver (CR, 32.9), stomach (CR, 21.6), colorectal (CR, 18.5), and pancreatic cancer (CR, 11.4). The top five causes of deaths from cancer in women included lung (CR, 18.5), colorectal (CR, 14.1), stomach (CR, 11.8), liver (CR, 11.5), and pancreatic cancer (CR, 9.9).

3. Trends in cancer incidence and mortality
-------------------------------------------

[Fig. 1](#f1-crt-2018-143){ref-type="fig"} shows the trends in cancer incidence and mortality from 1983 to 2015. The ASR for all-cancer incidence increased by 3.4% annually from 1999 to 2012, and then began to decrease from 2012 to 2015 (APC, --6.1%) ([Table 5](#t5-crt-2018-143){ref-type="table"}, [Fig. 1](#f1-crt-2018-143){ref-type="fig"}). The incidence of cancers in stomach, colorectum, lung and thyroid started to decrease around 2011. Especially, the ASR for thyroid cancer has increased rapidly 22.8% from 1999 to 2011, but then decreased swiftly 13.3% annually starting in 2011. Incidence of breast cancer has increased constantly throughout the period, but the APC slowly started to decrease since 2007. Conversely, the incidence rates of cervix and liver showed a constant decrease for the whole period. The incidence of liver cancer decreased drastically starting in 2010 ([Fig. 2](#f2-crt-2018-143){ref-type="fig"}).

The ASR for the all-cancer mortality rate has been increased until 2002 ([Table 6](#t6-crt-2018-143){ref-type="table"}, [Fig. 1](#f1-crt-2018-143){ref-type="fig"}). After that year, it began to decrease (2002-2015, APC, --2.7%). Similar patterns were observed in men and women. According to cancer sites, the mortality rates for most cancers including those of the lung, liver, colorectum, gallbladder, leukemia, brain and central nervous system, cervix uteri, and thyroid started to decrease in the early 2000s. However, the mortality rates for cancers of the stomach, larynx, testis, bladder, and non-Hodgkin lymphoma decreased starting in 1999 ([Fig. 3](#f3-crt-2018-143){ref-type="fig"}). Cancers in the pancreas, breast, and prostate showed constant increasing trends for the whole period.

4. Age-specific incidence
-------------------------

Leukemia was the most commonly diagnosed cancer among children aged 0-14 years ([Table 7](#t7-crt-2018-143){ref-type="table"}). Thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age. For men, the incidence rate of cancer increased before age 70 years ([Fig. 4A](#f4-crt-2018-143){ref-type="fig"}). Stomach cancer was the most commonly diagnosed cancer among men aged 35 to 64 years, while lung cancer was the most common among men aged ≥ 65 years. In contrast, breast cancer was most commonly diagnosed among women aged 35-64 years, while colorectal cancer was the most common among women aged ≥ 65 years. The incidence rates for thyroid and breast cancer showed an inverted U-shaped pattern when analyzed according to age ([Fig. 4B](#f4-crt-2018-143){ref-type="fig"}).

5. Survival rates
-----------------

The 5-year RSRs for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 70.7% in 2011-2015 ([Table 8](#t8-crt-2018-143){ref-type="table"}, [Fig. 5A](#f5-crt-2018-143){ref-type="fig"}). After excluding thyroid cancer, the 5-year RSRs for all cancer still increased from 1993 to 2015 ([Fig. 5B](#f5-crt-2018-143){ref-type="fig"}).

The 5-year RSR during 2011-2015 for all cancers combined was 62.8% in men and 78.4% in women, respectively. The 5-year RSR for thyroid cancer was over 100%, while the 5-year RSRs for testis, prostate, and breast cancer were over 90% in 2011-2015 for both sexes. However, the 5-year RSR for pancreatic cancer was only 10.8% in both sexes in 2011-2015.

When compared to the 5-year RSR for men in 1993-1995, prostate cancer diagnosed from 2011 to 2015 showed the most outstanding improvement, followed by stomach, leukemia, "lip, oral cavity and pharynx" and liver cancer. Among women, stomach cancer diagnosed during 2011-2015 showed the greatest improvement in 5-year RSRs compared to those between 1993 and 1995, followed by leukemia, lung, colorectal, and kidney cancer.

6. Prevalence
-------------

A total of 1,611,487 prevalent cancer cases were identified on January 1, 2016 ([Table 1](#t1-crt-2018-143){ref-type="table"}). Of these cases, 707,977 (43.9%) were men and 903,510 (56.1%) were women. The crude and age-standardized prevalence rates for overall cancer were 3,162.8 per 100,000 individuals and 1,956.9 per 100,000 individuals for both sexes, respectively, in 2015 ([Table 9](#t9-crt-2018-143){ref-type="table"}).

The five most common cancers for men were stomach (CR, 668.9), colorectal (CR, 516.8), prostate (CR, 272.8), thyroid (CR, 236.3), and liver cancer (CR, 180.2). In contrast, thyroid cancer was most common in women (CR, 1156.8), followed by breast (CR, 699.8), colorectal (CR, 349.4), stomach (CR, 340.1), and cervix uteri cancer (CR, 198.0).

Analysis of the period after cancer diagnosis revealed that thyroid (15.8%) cancer was the most prevalent cancer within 2 years after diagnosis, followed by stomach (14.3%) and colorectal cancer (13.2%) ([Fig. 6](#f6-crt-2018-143){ref-type="fig"}). Thyroid cancer (27.4%) was most prevalent for 2-5 years, followed by stomach (14.5%) and colorectal cancer (13.6%). After 5 years, thyroid cancer (21.7%) was the most prevalent cancer, followed by stomach (17.6%) and colorectal cancer (14.0%).
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![Trends in relative survival by year of diagnosis from 1999 to 2014. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.](crt-2018-143f5){#f5-crt-2018-143}

![Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2016 among all cancer patients diagnosed between 1999 and 2015.](crt-2018-143f6){#f6-crt-2018-143}

###### 

Cancer incidence, deaths and prevalence by sex in Korea, 2015

  Site/Type                                                    New cases   Deaths    Prevalent cases^[a)](#tfn1-crt-2018-143){ref-type="table-fn"}^                                                    
  ------------------------------------------------------------ ----------- --------- ---------------------------------------------------------------- -------- -------- -------- ----------- --------- ---------
  All sites                                                    214,701     113,335   101,366                                                          76,855   47,678   29,177   1,611,487   707,977   903,510
  Lip, oral cavity, and pharynx                                3,309       2,390     919                                                              1,170    884      286      21,827      14,656    7,171
  Esophagus                                                    2,420       2,201     219                                                              1,531    1,401    130      9,171       8,262     909
  Stomach                                                      29,207      19,545    9,662                                                            8,526    5,507    3,019    256,995     170,294   86,701
  Colon and rectum                                             26,790      15,911    10,879                                                           8,301    4,698    3,603    220,653     131,579   89,074
  Liver                                                        15,757      11,732    4,025                                                            11,311   8,382    2,929    61,290      45,881    15,409
  Gallbladder^[b)](#tfn2-crt-2018-143){ref-type="table-fn"}^   6,251       3,220     3,031                                                            4,211    2,135    2,076    19,468      9,958     9,510
  Pancreas                                                     6,342       3,359     2,983                                                            5,439    2,908    2,531    9,517       5,031     4,486
  Larynx                                                       1,146       1,079     67                                                               344      319      25       10,049      9,452     597
  Lung                                                         24,267      17,015    7,252                                                            17,399   12,677   4,722    69,931      43,987    25,944
  Breast                                                       19,219      77        19,142                                                           2,354    16       2,338    179,081     686       178,395
  Cervix uteri                                                 3,582       \-        3,582                                                            967      \-       3,582    50,477      \-        3,582
  Corpus uteri                                                 2,404       \-        2,404                                                            319      \-       2,404    20,859      \-        2,404
  Ovary                                                        2,443       \-        2,443                                                            1,055    \-       2,443    18,112      \-        2,443
  Prostate                                                     10,212      10,212    \-                                                               1,700    1,700    \-       69,438      69,438    \-
  Testis                                                       286         286       \-                                                               10       10       \-       2,939       2,939     \-
  Kidney                                                       4,555       3,134     1,421                                                            952      672      280      35,333      23,862    11,471
  Bladder                                                      4,033       3,245     788                                                              1,299    960      339      31,407      25,609    5,798
  Brain and CNS                                                1,776       958       818                                                              1,266    674      592      10,349      5,334     5,015
  Thyroid                                                      25,029      5,386     19,643                                                           341      106      235      355,057     60,151    294,906
  Hodgkin lymphoma                                             271         174       97                                                               49       33       16       2,571       1,623     948
  Non-Hodgkin lymphoma                                         4,396       2,519     1,877                                                            1,771    1,026    745      27,478      15,622    11,856
  Multiple myeloma                                             1,455       762       693                                                              889      466      423      5,330       2,779     2,551
  Leukemia                                                     3,242       1,830     1,412                                                            1,720    1,003    717      19,260      10,654    8,606
  Other and ill defined                                        16,309      8,300     8,009                                                            3,931    2,101    1,830    104,895     50,180    54,715

CNS, central nervous system.

Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

Include the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized cancer incidence rates by sex in Korea, 2015

  Site/Type                                                    Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn3-crt-2018-143){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    421.4                              445.2                                                                                        397.6   258.9   291.7   241.1
  Lip, oral cavity, and pharynx                                6.5                                9.4                                                                                          3.6     4.1     6.2     2.2
  Esophagus                                                    4.7                                8.6                                                                                          0.9     2.7     5.5     0.4
  Stomach                                                      57.3                               76.8                                                                                         37.9    33.8    49.3    20.5
  Colon and rectum                                             52.6                               62.5                                                                                         42.7    30.4    40.2    22.2
  Liver                                                        30.9                               46.1                                                                                         15.8    18.2    29.5    8.2
  Gallbladder^[b)](#tfn4-crt-2018-143){ref-type="table-fn"}^   12.3                               12.6                                                                                         11.9    6.6     8.0     5.5
  Pancreas                                                     12.4                               13.2                                                                                         11.7    7.0     8.5     5.7
  Larynx                                                       2.2                                4.2                                                                                          0.3     1.3     2.7     0.1
  Lung                                                         47.6                               66.8                                                                                         28.4    26.4    42.3    14.3
  Breast                                                       37.7                               0.3                                                                                          75.1    24.8    0.2     49.2
  Cervix uteri                                                 7.0                                \-                                                                                           14.1    4.6     \-      9.1
  Corpus uteri                                                 4.7                                \-                                                                                           9.4     3.1     \-      6.1
  Ovary                                                        4.8                                \-                                                                                           9.6     3.2     \-      6.3
  Prostate                                                     20.0                               40.1                                                                                         \-      11.2    25.4    \-
  Testis                                                       0.6                                1.1                                                                                          \-      0.6     1.1     \-
  Kidney                                                       8.9                                12.3                                                                                         5.6     5.7     8.2     3.4
  Bladder                                                      7.9                                12.7                                                                                         3.1     4.3     8.1     1.5
  Brain and CNS                                                3.5                                3.8                                                                                          3.2     2.8     3.1     2.4
  Thyroid                                                      49.1                               21.2                                                                                         77.1    35.2    15.1    55.6
  Hodgkin lymphoma                                             0.5                                0.7                                                                                          0.4     0.5     0.6     0.4
  Non-Hodgkin lymphoma                                         8.6                                9.9                                                                                          7.4     5.9     7.2     4.6
  Multiple myeloma                                             2.9                                3.0                                                                                          2.7     1.6     1.9     1.4
  Leukemia                                                     6.4                                7.2                                                                                          5.5     5.3     6.2     4.5
  Other and ill defined                                        32.0                               32.6                                                                                         31.4    19.7    22.6    17.4

CNS, central nervous system.

Age-adjusted using the Segi's world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The top 10 leading causes of death in Korea, 2015

  Rank   Cause of death                       No. of deaths (%)   Age-standardized death rate per 100,000^[a)](#tfn5-crt-2018-143){ref-type="table-fn"}^
  ------ ------------------------------------ ------------------- ----------------------------------------------------------------------------------------
         All causes                           275,895 (100)       289.3
  1      Cancer                               76,855 (27.9)       82.0
  2      Heart disease                        28,326 (10.3)       27.9
  3      Cerebrovascular disease              24,455 (8.9)        23.4
  4      Pneumonia                            14,718 (5.3)        13.5
  5      Intentional self-harm (suicide)      13,513 (4.9)        18.3
  6      Diabetes mellitus                    10,558 (3.8)        10.2
  7      Chronic lower respiratory diseases   7,538 (2.7)         6.8
  8      Disease of liver                     6,847 (2.5)         8.1
  9      Transport accidents                  5,539 (2.0)         7.6
  10     Hypertensive diseases                5,050 (1.8)         4.6
         Others                               82,496 (29.9)       87.1

Source: Mortality Data, 2015, Statistics Korea \[[@b8-crt-2018-143]\].

Age-adjusted using the Segi's world standard population.

###### 

Crude and age-standardized cancer mortality rates by sex in Korea, 2015

  Site/Type                                                    Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn6-crt-2018-143){ref-type="table-fn"}^                          
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                    150.8                              187.3                                                                                        114.4   82.0   119.6   54.6
  Lip, oral cavity, and pharynx                                2.3                                3.5                                                                                          1.1     1.3    2.3     0.6
  Esophagus                                                    3.0                                5.5                                                                                          0.5     1.6    3.4     0.2
  Stomach                                                      16.7                               21.6                                                                                         11.8    8.9    13.8    5.4
  Colon and rectum                                             16.3                               18.5                                                                                         14.1    8.5    11.8    6.1
  Liver                                                        22.2                               32.9                                                                                         11.5    12.6   20.9    5.4
  Gallbladder^[b)](#tfn7-crt-2018-143){ref-type="table-fn"}^   8.3                                8.4                                                                                          8.1     4.2    5.3     3.4
  Pancreas                                                     10.7                               11.4                                                                                         9.9     5.7    7.2     4.5
  Larynx                                                       0.7                                1.3                                                                                          0.1     0.4    0.8     0.0
  Lung                                                         34.1                               49.8                                                                                         18.5    17.9   31.2    8.2
  Breast                                                       4.6                                0.1                                                                                          9.2     2.8    0.0     5.5
  Cervix uteri                                                 1.9                                \-                                                                                           3.8     1.1    \-      2.0
  Corpus uteri                                                 0.6                                \-                                                                                           1.3     0.4    \-      0.7
  Ovary                                                        2.1                                \-                                                                                           4.1     1.2    \-      2.2
  Prostate                                                     3.3                                6.7                                                                                          \-      1.6    4.3     \-
  Testis                                                       0.0                                0.0                                                                                          \-      0.0    0.0     \-
  Kidney                                                       1.9                                2.6                                                                                          1.1     1.0    1.7     0.5
  Bladder                                                      2.5                                3.8                                                                                          1.3     1.2    2.4     0.5
  Brain and CNS                                                2.5                                2.6                                                                                          2.3     1.7    1.9     1.5
  Thyroid                                                      0.7                                0.4                                                                                          0.9     0.3    0.3     0.4
  Hodgkin lymphoma                                             0.1                                0.1                                                                                          0.1     0.1    0.1     0.0
  Non-Hodgkin lymphoma                                         3.5                                4.0                                                                                          2.9     2.0    2.7     1.4
  Multiple myeloma                                             1.7                                1.8                                                                                          1.7     1.0    1.2     0.8
  Leukemia                                                     3.4                                3.9                                                                                          2.8     2.2    2.8     1.7
  Other and ill defined                                        7.7                                8.3                                                                                          7.2     4.3    5.5     3.5

CNS, central nervous system.

Age-adjusted using the world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer incidence rates from 1999 to 2015 in Korea

  Site/Type                                                    Both sexes   Men     Women                                                                                                                                                                                                                                                                                                                                                                                        
  ------------------------------------------------------------ ------------ ------- ----------- ------------------------------------------------------ ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------ ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------ ----------- -------------------------------------------------------
  All sites                                                    210.5        258.9   1999-2012   3.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2012-2015   --6.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    285.0   291.7   1999-2011   1.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2011-2015   --3.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    161.1   241.1   1999-2012   5.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2012-2015   --7.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                3.6          4.1     1999-2015   0.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      6.1     6.2     1999-2015   --0.2                                                  \-          \-                                                      1.6     2.2     1999-2015   1.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Esophagus                                                    4.1          2.7     1999-2015   --2.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      8.8     5.5     1999-2015   --2.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      0.6     0.4     1999-2015   --1.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-
  Stomach                                                      43.6         33.8    1999-2011   --0.1                                                  2011-2015   --5.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    66.2    49.3    1999-2011   --0.3                                                  2011-2015   --6.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    26.7    20.5    1999-2011   --0.3                                                  2011-2015   --5.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Colon and rectum                                             20.4         30.4    1999-2010   6.0^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2010-2015   --4.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    26.2    40.2    1999-2010   6.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2010-2015   --5.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    16.4    22.2    1999-2010   4.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2010-2015   --4.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Liver                                                        27.9         18.2    1999-2010   --1.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   2010-2015   --4.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    46.8    29.5    1999-2009   --1.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   2009-2015   --4.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    12.3    8.2     1999-2010   --1.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   2010-2015   --5.0^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn9-crt-2018-143){ref-type="table-fn"}^   6.5          6.6     1999-2004   1.5                                                    2004-2015   --0.3                                                   8.1     8.0     1999-2015   0.0                                                    \-          \-                                                      5.4     5.5     1999-2003   2.5                                                    2003-2015   --0.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Pancreas                                                     5.6          7.0     1999-2015   1.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      7.8     8.5     1999-2015   0.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      4.0     5.7     1999-2015   2.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Larynx                                                       2.3          1.3     1999-2015   --3.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      4.9     2.7     1999-2015   --3.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      0.4     0.1     1999-2007   --8.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   2007-2015   --4.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Lung                                                         28.5         26.4    1999-2011   0.1                                                    2011-2015   --1.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    51.4    42.3    1999-2005   --0.1                                                  2005-2015   --1.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    12.4    14.3    1999-2012   1.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2012-2015   --2.0
  Breast                                                       10.7         24.8    1999-2007   6.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2007-2015   4.0^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^      0.2     0.2     1999-2015   --1.1                                                  \-          \-                                                      20.9    49.2    1999-2007   7.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2007-2015   4.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Cervix uteri                                                 8.5          4.6     1999-2015   --3.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      \-      \-      \-          \-                                                     \-          \-                                                      16.3    9.1     1999-2015   --3.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   \-          \-
  Corpus uteri                                                 1.4          3.1     1999-2009   6.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2009-2015   3.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^      \-      \-      \-          \-                                                     \-          \-                                                      2.8     6.1     1999-2009   6.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2009-2015   3.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Ovary                                                        2.7          3.2     1999-2015   1.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      \-      \-      \-          \-                                                     \-          \-                                                      5.0     6.3     1999-2015   1.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Prostate                                                     3.1          11.2    1999-2009   15.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    2009-2015   0.3                                                     8.4     25.4    1999-2009   13.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    2009-2015   --0.5                                                   \-      \-      \-          \-                                                     \-          \-
  Testis                                                       0.3          0.6     1999-2015   4.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      0.6     1.1     1999-2015   4.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      \-      \-      \-          \-                                                     \-          \-
  Kidney                                                       3.0          5.7     1999-2009   6.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2009-2015   1.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^      4.5     8.2     1999-2010   6.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2010-2015   0.4                                                     1.7     3.4     1999-2009   6.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2009-2015   1.1
  Bladder                                                      4.6          4.3     1999-2004   2.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2004-2015   --1.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    9.0     8.1     1999-2005   1.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2005-2015   --1.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    1.6     1.5     1999-2003   2.6                                                    2003-2015   --1.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Brain and CNS                                                2.9          2.8     1999-2008   1.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2008-2015   --1.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    3.2     3.1     1999-2009   1.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2009-2015   --2.0                                                   2.6     2.4     1999-2007   1.5                                                    2007-2015   --1.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Thyroid                                                      6.3          35.2    1999-2011   22.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    2011-2015   --13.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   2.1     15.1    1999-2012   22.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    2012-2015   --16.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^   10.4    55.6    1999-2011   22.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^    2011-2015   --14.4^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^
  Hodgkin lymphoma                                             0.2          0.5     1999-2015   4.1^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      0.4     0.6     1999-2015   3.2^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      0.1     0.4     1999-2015   5.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Non-Hodgkin lymphoma                                         4.3          5.9     1999-2015   2.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      5.6     7.2     1999-2015   1.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      3.3     4.6     1999-2015   2.6^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Multiple myeloma                                             1.0          1.6     1999-2015   3.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      1.2     1.9     1999-2015   3.0^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      0.8     1.4     1999-2015   3.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Leukemia                                                     4.7          5.3     1999-2015   0.9^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      5.5     6.2     1999-2015   1.0^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      3.9     4.5     1999-2015   0.7^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-
  Other and ill defined                                        14.4         19.7    1999-2008   3.5^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2008-2015   1.3^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^      18.1    22.6    1999-2015   1.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      11.9    17.4    1999-2011   3.8^[a)](#tfn8-crt-2018-143){ref-type="table-fn"}^     2011-2015   --0.3

APC was calculated using age-standardized incidence data based on the Segi's world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Trends in cancer mortality rates from 1999 to 2015 in Korea

  Site/Type                                                     Both sexes   Men    Women                                                                                                                                                                                                                                                                                                                                                                                          
  ------------------------------------------------------------- ------------ ------ ----------- ------------------------------------------------------- ----------- ------------------------------------------------------- ------- ------- ----------- ------------------------------------------------------- ----------- ------------------------------------------------------- ------ ------ ----------- -------------------------------------------------------- ----------- -------------------------------------------------------
  All sites                                                     114.3        82.0   1999-2002   1.0                                                     2002-2015   --2.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   176.6   119.6   1999-2002   1.2                                                     2002-2015   --3.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   70.6   54.6   1999-2002   1.0                                                      2002-2015   --2.2^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Lip, oral cavity, and pharynx                                 1.1          1.3    1999-2015   --1.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      2.0     2.3     1999-2015   --2.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      0.4    0.6    1999-2015   --2.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    \-          \-
  Esophagus                                                     3.1          1.6    1999-2015   --4.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      6.8     3.4     1999-2015   --4.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      0.5    0.2    1999-2015   --5.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    \-          \-
  Stomach                                                       23.8         8.9    1999-2003   --3.3^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   2003-2015   --6.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   36.9    13.8    1999-2003   --2.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   2003-2015   --7.0^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   14.6   5.4    1999-2003   --4.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2003-2015   --6.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Colon and rectum                                              7.7          8.5    1999-2004   5.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     2004-2015   --1.3^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   10.5    11.8    1999-2004   5.9^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     2004-2015   --1.0^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   6.0    6.1    1999-2004   4.9^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^      2004-2015   --1.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Liver                                                         20.4         12.6   1999-2002   0.8                                                     2002-2015   --3.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   35.3    20.9    1999-2002   --0.1                                                   2002-2015   --3.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   8.3    5.4    1999-2002   2.9                                                      2002-2015   --3.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Gallbladder^[b)](#tfn11-crt-2018-143){ref-type="table-fn"}^   5.2          4.2    1999-2001   7.4                                                     2001-2015   --2.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   6.8     5.3     1999-2001   6.2                                                     2001-2015   --2.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   4.1    3.4    1999-2001   9.2                                                      2001-2015   --2.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Pancreas                                                      5.4          5.7    1999-2015   0.3^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      7.6     7.2     1999-2015   --0.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      3.9    4.5    1999-2015   0.9^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^      \-          \-
  Larynx                                                        1.6          0.4    1999-2015   --9.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      3.4     0.8     1999-2015   --9.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      0.4    0.0    1999-2010   --15.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   2010-2015   --6.2
  Lung                                                          22.4         17.9   1999-2002   1.8                                                     2002-2015   --2.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   41.5    31.2    1999-2001   4.3                                                     2001-2015   --2.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   9.4    8.2    1999-2002   2.3                                                      2002-2015   --1.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Breast                                                        2.2          2.8    1999-2015   1.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     \-          \-                                                      0.1     0.0     1999-2015   --4.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      4.2    5.5    1999-2015   1.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^      \-          \-
  Cervix uteri                                                  1.4          1.1    1999-2003   8.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     2003-2015   --5.2^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-      \-      \-          \-                                                      \-          \-                                                      2.6    2.0    1999-2003   7.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^      2003-2015   --4.9^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Corpus uteri                                                  0.1          0.4    1999-2002   51.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2002-2015   3.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     \-      \-      \-          \-                                                      \-          \-                                                      0.1    0.7    1999-2002   51.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     2002-2015   3.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Ovary                                                         0.9          1.2    1999-2001   10.9                                                    2001-2015   0.2                                                     \-      \-      \-          \-                                                      \-          \-                                                      1.7    2.2    1999-2001   10.2                                                     2001-2015   0.5
  Prostate                                                      0.9          1.6    1999-2004   9.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^     2004-2015   0.4                                                     2.6     4.3     1999-2002   17.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2002-2015   0.3                                                     \-     \-     \-          \-                                                       \-          \-
  Testis                                                        0.0          0.0    1999-2015   --2.5                                                   \-          \-                                                      0.1     0.0     1999-2015   --2.9                                                   \-          \-                                                      \-     \-     \-          \-                                                       \-          \-
  Kidney                                                        1.1          1.0    1999-2015   --0.1                                                   \-          \-                                                      1.8     1.7     1999-2015   0.0                                                     \-          \-                                                      0.5    0.5    1999-2015   --0.8                                                    \-          \-
  Bladder                                                       1.3          1.2    1999-2015   --1.3^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      2.6     2.4     1999-2015   --1.6^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      0.5    0.5    1999-2001   10.8                                                     2001-2015   --1.9^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Brain and CNS                                                 1.9          1.7    1999-2002   4.4                                                     2002-2015   --2.0^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   2.2     1.9     1999-2015   --1.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      1.6    1.5    1999-2015   --1.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    \-          \-
  Thyroid                                                       0.4          0.3    1999-2003   7.0                                                     2003-2015   --4.2^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   0.3     0.3     1999-2002   16.0                                                    2002-2015   --4.0^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   0.5    0.4    1999-2004   4.3                                                      2004-2015   --4.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^
  Hodgkin lymphoma                                              0.0          0.1    1999-2003   29.6                                                    2003-2015   --0.2                                                   0.0     0.1     1999-2004   19.2^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2004-2015   --2.0                                                   0.0    0.0    1999-2003   40.8                                                     2003-2015   1.3
  Non-Hodgkin lymphoma                                          2.1          2.0    1999-2015   --0.5^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      3.0     2.7     1999-2015   --0.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      1.4    1.4    1999-2015   --0.2                                                    \-          \-
  Multiple myeloma                                              0.6          1.0    1999-2003   12.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2003-2015   0.8                                                     0.8     1.2     1999-2003   10.9^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2003-2015   0.8                                                     0.4    0.8    1999-2007   7.4^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^      2007-2015   --1.1
  Leukemia                                                      2.9          2.2    1999-2001   1.4                                                     2001-2015   --2.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   3.5     2.8     1999-2015   --1.7^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      2.4    1.7    1999-2015   --2.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    \-          \-
  Other and ill defined                                         7.8          4.3    1999-2015   --3.1^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   \-          \-                                                      9.0     5.5     1999-2009   --0.6                                                   2009-2015   --6.8^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^   7.0    3.5    1999-2005   --7.0^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^    2005-2015   --2.2^[a)](#tfn10-crt-2018-143){ref-type="table-fn"}^

APC was calculated using age-standardized incidence data based on the Segi's world standard population. APC, annual percentage change; CNS, central nervous system.

Significantly different from zero (p \< 0.05),

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

The five common sites/types of cancer incidence by age group and sex in Korea, 2015

  Rank        Age (yr)                                                                            
  ----------- ---------------------------- ---------------------------- ------------------------- --------------------------
  **Men**                                                                                         
   1          Leukemia (4.7)               Thyroid (11.9)               Stomach (81.9)            Lung (436.0)
   2          Non-Hodgkin lymphoma (2.7)   Leukemia (3.8)               Colon and rectum (62.9)   Stomach (353.5)
   3          Brain and CNS (1.9)          Non-Hodgkin lymphoma (2.8)   Liver (56.9)              Colon and rectum (300.4)
   4          Kidney (0.5)                 Colon and rectum (2.7)       Lung (42.1)               Prostate (284.2)
   5          Liver (0.4)                  Testis (2.3)                 Thyroid (33.7)            Liver (178.7)
  **Women**                                                                                       
   1          Leukemia (4.1)               Thyroid (45.9)               Breast (132.5)            Colon and rectum (168.4)
   2          Brain and CNS (1.6)          Breast (10.9)                Thyroid (125.6)           Stomach (137.0)
   3          Non-Hodgkin lymphoma (1.5)   Cervix uteri (5.2)           Colon and rectum (37.0)   Lung (122.1)
   4          Thyroid (0.9)                Ovary (3.0)                  Stomach (36.5)            Breast (78.2)
   5          Ovary (0.6)                  Stomach (2.9)                Lung (21.9)               Live (66.3)

CNS, central nervous system.

###### 

Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2015 in Korea

  Site/Type                                                     Both sexes   Men    Women                                                                                                         
  ------------------------------------------------------------- ------------ ------ ------- ------ ------- ------ ------ ------ ------ ------- ------- ------ ------ ------ ------ ------ ------- ------
  All sites                                                     41.2         44.0   54.0    65.2   70.7    29.5   31.7   35.3   45.4   56.5    62.8    31.1   53.4   55.3   64.2   74.2   78.4    25.0
  Lip, oral cavity, and pharynx                                 41.1         46.7   54.3    60.6   64.5    23.4   35.8   41.1   49.4   56.4    60.7    24.9   58.1   63.8   67.8   71.7   74.1    16.0
  Esophagus                                                     12.7         15.2   21.4    29.6   36.0    23.3   11.8   14.3   20.6   29.0    35.7    23.9   23.7   24.2   29.7   36.5   39.3    15.6
  Stomach                                                       42.8         46.6   57.8    68.1   75.4    32.6   43.0   46.9   58.4   68.7    76.3    33.3   42.6   46.0   56.5   66.7   73.7    31.1
  Colon and rectum                                              54.8         58.0   66.7    73.5   76.3    21.5   55.3   59.0   68.5   75.4    78.0    22.7   54.2   56.8   64.3   70.8   73.6    19.4
  Liver                                                         10.7         13.2   20.4    28.1   33.6    22.9   9.9    12.9   20.3   28.1    34.1    24.2   13.6   14.2   20.9   28.1   32.2    18.6
  Gallbladder^[b)](#tfn13-crt-2018-143){ref-type="table-fn"}^   17.3         19.7   23.1    26.8   29.1    11.8   16.6   20.3   23.5   27.7    30.2    13.6   18.0   19.1   22.7   25.9   28.0    10.0
  Pancreas                                                      9.4          7.6    8.4     8.4    10.8    1.4    8.8    7.3    8.4    8.1     10.3    1.5    10.1   8.1    8.5    8.7    11.5    1.4
  Larynx                                                        59.7         62.3   66.3    72.9   75.5    15.8   60.2   62.8   66.9   73.2    75.9    15.7   55.4   57.8   58.9   67.6   69.9    14.5
  Lung                                                          11.3         12.7   16.5    20.1   26.7    15.4   10.4   11.6   15.2   17.9    22.7    12.3   14.2   16.2   20.1   25.8   35.8    21.6
  Breast                                                        77.9         83.2   88.6    91.1   92.3    14.4   75.1   85.6   87.2   89.9    87.1    12.0   78.0   83.2   88.6   91.1   92.3    14.3
  Cervix uteri                                                  77.5         80.0   81.4    80.5   79.9    2.4    \-     \-     \-     \-      \-      \-     77.5   80.0   81.4   80.5   79.9    2.4
  Corpus uteri                                                  81.5         81.8   84.5    86.4   87.8    6.3    \-     \-     \-     \-      \-      \-     81.5   81.8   84.5   86.4   87.8    6.3
  Ovary                                                         58.7         58.9   61.8    61.1   64.1    5.4    \-     \-     \-     \-      \-      \-     58.7   58.9   61.8   61.1   64.1    5.4
  Prostate                                                      55.9         67.2   80.4    91.1   94.1    38.2   55.9   67.2   80.4   91.1    94.1    38.2   \-     \-     \-     \-     \-      \-
  Testis                                                        85.4         90.4   90.7    93.1   95.6    10.2   85.4   90.4   90.7   93.1    95.6    10.2   \-     \-     \-     \-     \-      \-
  Kidney                                                        62.0         66.1   73.6    78.4   82.2    20.2   60.8   64.4   73.0   78.2    81.6    20.8   64.5   69.7   74.7   78.8   83.6    19.1
  Bladder                                                       69.1         73.1   75.7    76.7   75.8    6.7    70.0   74.8   77.5   78.8    77.8    7.8    65.5   66.3   68.8   68.6   67.7    2.2
  Brain and CNS                                                 38.5         39.0   40.9    42.8   40.7    2.2    37.2   37.5   40.2   41.4    39.1    1.9    40.2   40.7   41.7   44.4   42.6    2.4
  Thyroid                                                       94.2         94.9   98.4    99.9   100.3   6.1    87.2   89.5   96.0   100.1   100.6   13.4   95.4   95.9   98.7   99.9   100.2   4.8
  Hodgkin lymphoma                                              68.0         71.2   76.7    81.0   82.2    14.2   67.6   68.1   74.7   80.7    82.8    15.2   68.6   77.4   80.7   81.6   81.2    12.6
  Non-Hodgkin lymphoma                                          46.6         50.8   55.9    59.3   62.9    16.3   45.3   48.9   54.9   59.1    62.4    17.1   48.7   53.5   57.4   59.6   63.6    14.9
  Multiple myeloma                                              22.1         19.8   29.6    34.9   40.9    18.8   21.1   17.8   29.8   35.0    40.6    19.5   23.3   22.1   29.4   34.8   41.3    18.0
  Leukemia                                                      26.5         33.3   42.0    47.6   51.0    24.5   26.2   32.3   41.8   46.8    51.1    24.9   26.8   34.6   42.2   48.6   50.8    24.0
  Other and ill defined                                         42.1         45.9   57.6    67.2   72.2    30.1   37.4   42.4   53.8   63.4    68.9    31.5   47.4   50.0   61.8   71.0   75.5    28.1

CNS, central nervous system.

Percentage change in 5-year relative survival from 1993 to 1995 and 2011 to 2015,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2016 in Korea

  Site/Type                                                     Crude prevalence rate per 100,000^[a)](#tfn14-crt-2018-143){ref-type="table-fn"}^   Age-standardized prevalence rate per 100,000^[b)](#tfn15-crt-2018-143){ref-type="table-fn"}^                                 
  ------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------- --------- --------- ---------
  All sites                                                     3,162.8                                                                             2,781.0                                                                                        3,544.1   1,956.9   1,826.6   2,171.5
  Lip, oral cavity, and pharynx                                 42.8                                                                                57.6                                                                                           28.1      26.8      37.9      17.2
  Esophagus                                                     18.0                                                                                32.5                                                                                           3.6       10.3      20.6      1.8
  Stomach                                                       504.4                                                                               668.9                                                                                          340.1     291.5     425.6     180.9
  Colon and rectum                                              433.1                                                                               516.8                                                                                          349.4     248.2     330.6     181.7
  Liver                                                         120.3                                                                               180.2                                                                                          60.4      73.5      116.8     34.2
  Gallbladder^[c)](#tfn16-crt-2018-143){ref-type="table-fn"}^   38.2                                                                                39.1                                                                                           37.3      21.1      24.7      18.4
  Pancreas                                                      18.7                                                                                19.8                                                                                           17.6      11.1      12.9      9.7
  Larynx                                                        19.7                                                                                37.1                                                                                           2.3       11.2      23.6      1.2
  Lung                                                          137.2                                                                               172.8                                                                                          101.8     78.7      110.2     54.5
  Breast                                                        351.5                                                                               2.7                                                                                            699.8     221.7     1.7       435.9
  Cervix uteri                                                  99.1                                                                                \-                                                                                             198.0     61.5      \-        120.0
  Corpus uteri                                                  40.9                                                                                \-                                                                                             81.8      26.1      \-        51.2
  Ovary                                                         35.5                                                                                \-                                                                                             71.0      24.2      \-        48.1
  Prostate                                                      136.3                                                                               272.8                                                                                          \-        71.3      170.0     \-
  Testis                                                        5.8                                                                                 11.5                                                                                           \-        5.2       10.3      \-
  Kidney                                                        69.3                                                                                93.7                                                                                           45.0      43.5      62.0      27.1
  Bladder                                                       61.6                                                                                100.6                                                                                          22.7      33.7      64.1      10.6
  Brain and CNS                                                 20.3                                                                                21.0                                                                                           19.7      17.2      18.3      16.1
  Thyroid                                                       696.8                                                                               236.3                                                                                          1,156.8   464.9     160.2     767.5
  Hodgkin lymphoma                                              5.0                                                                                 6.4                                                                                            3.7       4.2       5.1       3.2
  Non-Hodgkin lymphoma                                          53.9                                                                                61.4                                                                                           46.5      38.2      45.9      31.1
  Multiple myeloma                                              10.5                                                                                10.9                                                                                           10.0      6.1       7.0       5.4
  Leukemia                                                      37.8                                                                                41.8                                                                                           33.8      35.2      39.2      31.1
  Other and ill defined                                         205.9                                                                               197.1                                                                                          214.6     131.4     139.9     124.4

CNS, central nervous system.

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2015 and who were alive on January 1, 2016. Multiple primary cancer cases were counted multiple times,

Age-adjusted using the Segi's world standard population,

Includes the gallbladder and other/unspecified parts of the biliary tract.

[^1]: The members of the group are listed at the end of this article.
